The open book of infectious diseases

Nature Medicine

Volumn 13, Issue 3, 2007, Pages 279-280

  Sassetti, Christopher M ^a   Rubin, Eric J ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHEMICAL COMPOUND; ISONIAZID; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OPC 67863; QUINOLINE DERIVATIVE; TMC 207; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; DNA POLYMORPHISM; DRUG EFFICACY; DRUG TARGETING; HUMAN; INFECTION; MICROBIAL POPULATION DYNAMICS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; SHORT SURVEY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTIBIOTICS, ANTITUBERCULAR; COMMUNICABLE DISEASE CONTROL; FORECASTING; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 33847726667     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0307-279     Document Type: Short Survey

References (8)

1. The Office of the Historian of the Public Health Service. 〈http://lhncbc.nlm.nih.gov/apdb/phsHistory/faqs.html〉 (2004).
2. Salomon, J.A. et al. PLoS Med. 3, e273 (2006).
3. Andries, K. et al. Science 307, 223-227 (2005).
4. Stover, C.K. et al. Nature 405, 962-966 (2000).
5. Matsumoto, M. et al. PLoS Med. 3, e466 (2006).
6. Vilcheze, C. et al. Nat. Med. 12, 1027-1029 (2006).
7. Rengarajan, J. et al. Mol. Microbiol. 53, 275-282 (2004).
8. Manjunatha, U.H. et al. Proc. Natl. Acad. Sci. USA 103, 431-436 (2006).